top of page

VIROMARKERS at the EMHH 2026

  • 2 days ago
  • 2 min read

The VIROMARKERS consortium took part in the 24th European Meeting on HIV & Hepatitis (EMHH 2026), where project partners contributed with oral presentations, posters and invited lectures presenting recent results and ongoing work.

The conference was a useful opportunity to exchange ideas, discuss current research questions and explore new directions in the field.

It also allowed consortium members to meet in person, strengthen collaborations and connect with colleagues from other groups.


We thank the organisers, speakers and participants for contributing to a productive and engaging meeting!




Discover all the VIROMARKERS presentations at EMHH 2026 below.


Invited oral lectures:

HIV DNA as a Biomarker - Ready for the Clinic?

Maria Santoro (UTOV)


Role of Novel Biomarkers for HBV-HDV

Valentina Svicher (UTOV)


Second Generation INSTI resistance - Noncanonical Resistance Mutations

Francesca Ceccherini-Silberstein (UTOV)


Oral presentations:

HBsAg isoforms vary according to HDV subgenotypes and their levels distinguish the different disease stages of chronic HDV infection

Stefano D’Anna (UTOV)


Hepatitis Delta antigen and ribozyme genetic variability is associated with altered virological and biochemical markers and provides basis for the identification of novel therapeutic targets

Alessia Magnapera (UTOV)


Multidisciplinary assessment of the HIV-1 reservoir after switching from triple to dual antiretroviral therapy in virologically suppressed individuals, a prospective observational pilot study

Niccolò Bartolini (UniSiena)


Posters:

Extensive HDV genetic diversity and high rates of active infection in Cameroon revealed by molecular diagnostics and Whole‑Genome Sequencing

Lorenzo Piermatteo (UTOV)


Improving CMV surveillance in allogeneic HSCT during and after letermovir prophylaxis: CMV-RNA as a marker of active replication

Caterina Tramontozzi (UTOV)


Europe is still characterized by a relevant burden of HDV infection and double reflex testing can be valuable to increase HDV diagnosis at an earlier stage of liver disease

Ilaria Grossi (UTOV)


Quantitative Profile of Proviral Hiv-Dna during Low-Level Viremia among Adolescents with Perinatally Acquired HIV Receiving Dolutegravir-Based Regimen in Cameroon

Forgwei Lum Yah (Chantal Biya International Reference Centre/UTOV)


Characterization of HIV-1 Non Canonical Mutations in Cameroonians who failed a DTG-based regimen

Forgwei Lum Yah (Chantal Biya International Reference Centre/UTOV)

poster tour presented by:

Naomi-karell Etame (Chantal Biya International Reference Centre/UTOV)


 
 

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement
No 101194735. The JU receives support from the European Union’s Horizon Europe research and innovation
programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe and Roboscreen.

All IHI partner logos_1 line.png
  • Instagram
  • LinkedIn
Screenshot 2026-01-08 alle 17.33.44.png
bottom of page